(Q35014158)

5 August 2017

1 reference

title

Toxoplasmosis, an overview with emphasis on ocular involvement (English)

1 reference

5 August 2017

0 references

2

Aize Kijlstra

1 reference

5 August 2017

Vincent N A Klaren

1

1 reference

5 August 2017

1 March 2002

1 reference

Ocular Immunology and Inflammation

5 August 2017

1 reference

5 August 2017

10

1 reference

5 August 2017

1

1 reference

5 August 2017

1-26

1 reference

Transmission of Toxoplasma gondii infection by liver transplantation.

5 August 2017

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Pathophysiology of toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Feline toxoplasmosis from acutely infected mice and the development of Toxoplasma cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Neurocysticercosis and acquired cerebral toxoplasmosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasmic infection in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

The resistance of the encysted form of Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Evolution. Parasites make scaredy-rats foolhardy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Fatal attraction in rats infected with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Molecular and biochemical aspects of nematode collagens

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Regional variation in toxoplasmosis seronegativity in the São Paulo metropolitan region

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

HLA-class II genes modify outcome of Toxoplasma gondii infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Reconsidering the pathogenesis of ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Outbreak of toxoplasmosis in a family and documentation of acquired retinochoroiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasmosis infection associated with raw goat's milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Potential contamination of drinking water with Toxoplasma gondii oocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Analysis of ocular fluids for local antibody production in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

A plastid of probable green algal origin in Apicomplexan parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Interferon-gamma: the major mediator of resistance against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Down-regulation of MHC class II molecules and inability to up-regulate class I molecules in murine macrophages after infection with Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Human Toxoplasma gondii-specific secretory immunoglobulin A reduces T. gondii infection of enterocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Recognition and characterization of stage-specific oocyst/sporozoite antigens of Toxoplasma gondii by human antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasma gondii infection: analysis of serological response by 2-DE immunoblotting

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Evidence for a compartmentalized B cell response as characterized by IgG epitope specificity in human ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Immunoregulatory mechanisms of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasma gondii Cysts in Cell Culture: New Biologic Evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

EVOLUTION: Parasites Make Scaredy-Rats Foolhardy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasma gondii: differentiation and death of bradyzoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Prevalence of antibodies to Toxoplasma gondii in cattle and swine in The Netherlands: towards an integrated control of livestock production

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasma gondii strain-specific transcript levels of SAG1 and their association with virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Results of 20-year follow-up of congenital toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

21 January 2018

Acquired toxoplasmosis

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Lymphocyte responses to retinal-specific antigens in uveitis patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Congenital toxoplasmic retinochoroiditis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Dense-granule organelles of Toxoplasma gondii: their role in the host-parasite relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Lack of evidence for superantigen activity of Toxoplasma gondii towards human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Definitive Serological Diagnosis of Ocular Toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Differences between intraocular and serum antibody responses in patients with ocular toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

Immunoregulatory mechanisms of the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.10.1.1.10330

10.1076/OCII.10.1.1.10330

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12461700